I don't think management care about SP or promoting the company. They seem stuck on a path that they don't promote albeit they have listed a list of targets for 2024. I think that they believe the SP increase will happen with success in achieving drug approval for indications other than EPP. Even the recently announced BB doesn't seem to be aggressive just yet - it seemed like the BB is going to be used to push the SP aggressively higher when some good news is released. I think the only reason the BB was conceded at all is because of the risk of a 2nd strike at the next AGM. That AGM is only a few months away so I think we're in for a very interesting period between now and then.
In truth, I haven't a clue what's gounding on as this is the most puzzling of companies:
* SP at a very low level
* Shorts still increasing *
* Several trials underway that should lead to lucrative markets
* Management quite reluctant to detail progress
I think much will be revealed (good or bad) in 2024.
I don't think management care about SP or promoting the company....
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.44 |
Change
0.050(0.32%) |
Mkt cap ! $770.0M | |||
| Open | High | Low | Value | Volume |
| $15.34 | $15.51 | $15.18 | $566.5K | 36.78K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 405 | $15.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.44 | 294 | 10 |
View Market Depth
| Last trade - 15.45pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$15.45 |
Change
0.050 ( 1.07 %) |
||||
| Open | High | Low | Volume | ||
| $15.30 | $15.50 | $15.23 | 6424 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| CUV (ASX) Chart |